BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 38236599)

  • 1. Cannabis and Driving in Older Adults.
    Di Ciano P; Rajji TK; Hong L; Zhao S; Byrne P; Elzohairy Y; Brubacher JR; McGrath M; Brands B; Chen S; Wang W; Hasan OSM; Wickens CM; Kaduri P; Le Foll B
    JAMA Netw Open; 2024 Jan; 7(1):e2352233. PubMed ID: 38236599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Cannabidiol and Δ9-Tetrahydrocannabinol on Driving Performance: A Randomized Clinical Trial.
    Arkell TR; Vinckenbosch F; Kevin RC; Theunissen EL; McGregor IS; Ramaekers JG
    JAMA; 2020 Dec; 324(21):2177-2186. PubMed ID: 33258890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of cannabis edibles on driving and blood THC.
    Zhao S; Brands B; Kaduri P; Wickens CM; Hasan OSM; Chen S; Le Foll B; Di Ciano P
    J Cannabis Res; 2024 May; 6(1):26. PubMed ID: 38822413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of Orally Administered Δ9-Tetrahydrocannabinol When Coadministered With Cannabidiol on Δ9-Tetrahydrocannabinol Pharmacokinetics and Pharmacodynamics in Healthy Adults: A Randomized Clinical Trial.
    Zamarripa CA; Spindle TR; Surujunarain R; Weerts EM; Bansal S; Unadkat JD; Paine MF; Vandrey R
    JAMA Netw Open; 2023 Feb; 6(2):e2254752. PubMed ID: 36780161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simulated driving performance among daily and occasional cannabis users.
    Brooks-Russell A; Brown T; Friedman K; Wrobel J; Schwarz J; Dooley G; Ryall KA; Steinhart B; Amioka E; Milavetz G; Sam Wang G; Kosnett MJ
    Accid Anal Prev; 2021 Sep; 160():106326. PubMed ID: 34403895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Utility of THC Cutoff Levels in Blood and Saliva for Detection of Impaired Driving.
    Di Ciano P; Brands B; Fares A; Wright M; Stoduto G; Byrne P; McGrath M; Hasan OSM; Le Foll B; Wickens CM
    Cannabis Cannabinoid Res; 2023 Jun; 8(3):408-413. PubMed ID: 36730769
    [No Abstract]   [Full Text] [Related]  

  • 7. Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition.
    Arkell TR; Lintzeris N; Kevin RC; Ramaekers JG; Vandrey R; Irwin C; Haber PS; McGregor IS
    Psychopharmacology (Berl); 2019 Sep; 236(9):2713-2724. PubMed ID: 31044290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of CannEpil
    Manning B; Hayley AC; Catchlove S; Shiferaw B; Stough C; Downey LA
    J Psychopharmacol; 2023 May; 37(5):472-483. PubMed ID: 37129083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Driving Performance and Cannabis Users' Perception of Safety: A Randomized Clinical Trial.
    Marcotte TD; Umlauf A; Grelotti DJ; Sones EG; Sobolesky PM; Smith BE; Hoffman MA; Hubbard JA; Severson J; Huestis MA; Grant I; Fitzgerald RL
    JAMA Psychiatry; 2022 Mar; 79(3):201-209. PubMed ID: 35080588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Field Sobriety Tests for Identifying Drivers Under the Influence of Cannabis: A Randomized Clinical Trial.
    Marcotte TD; Umlauf A; Grelotti DJ; Sones EG; Mastropietro KF; Suhandynata RT; Huestis MA; Grant I; Fitzgerald RL
    JAMA Psychiatry; 2023 Sep; 80(9):914-923. PubMed ID: 37531115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabis effects on driving lateral control with and without alcohol.
    Hartman RL; Brown TL; Milavetz G; Spurgin A; Pierce RS; Gorelick DA; Gaffney G; Huestis MA
    Drug Alcohol Depend; 2015 Sep; 154():25-37. PubMed ID: 26144593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The acute effects of cannabis with and without cannabidiol in adults and adolescents: A randomised, double-blind, placebo-controlled, crossover experiment.
    Lawn W; Trinci K; Mokrysz C; Borissova A; Ofori S; Petrilli K; Bloomfield M; Haniff ZR; Hall D; Fernandez-Vinson N; Wang S; Englund A; Chesney E; Wall MB; Freeman TP; Curran HV
    Addiction; 2023 Jul; 118(7):1282-1294. PubMed ID: 36750134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Driving Under the Influence of Cannabis: Impact of Combining Toxicology Testing with Field Sobriety Tests.
    Fitzgerald RL; Umlauf A; Hubbard JA; Hoffman MA; Sobolesky PM; Ellis SE; Grelotti DJ; Suhandynata RT; Huestis MA; Grant I; Marcotte TD
    Clin Chem; 2023 Jul; 69(7):724-733. PubMed ID: 37228223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A semi-naturalistic open-label study examining the effect of prescribed medical cannabis use on simulated driving performance.
    Manning B; Arkell TR; Hayley AC; Downey LA
    J Psychopharmacol; 2024 Mar; 38(3):247-257. PubMed ID: 38332655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knowledge of Tetrahydrocannabinol and Cannabidiol Levels Among Cannabis Consumers in the United States and Canada.
    Hammond D; Goodman S
    Cannabis Cannabinoid Res; 2022 Jun; 7(3):345-354. PubMed ID: 33998866
    [No Abstract]   [Full Text] [Related]  

  • 16. The failings of
    Arkell TR; Spindle TR; Kevin RC; Vandrey R; McGregor IS
    Traffic Inj Prev; 2021; 22(2):102-107. PubMed ID: 33544004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined effect of alcohol and cannabis on simulated driving.
    Fares A; Wickens CM; Mann RE; Di Ciano P; Wright M; Matheson J; Hasan OSM; Rehm J; George TP; Samokhvalov AV; Shuper PA; Huestis MA; Stoduto G; Brown T; Stefan C; Rubin-Kahana DS; Le Foll B; Brands B
    Psychopharmacology (Berl); 2022 May; 239(5):1263-1277. PubMed ID: 33544195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting changes in driving performance in individuals who use cannabis following acute use based on self-reported readiness to drive.
    Miller R; Brown T; Schmitt R; Gaffney G; Milavetz G
    Accid Anal Prev; 2024 Feb; 195():107376. PubMed ID: 37984112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic Profile of ∆9-Tetrahydrocannabinol, Cannabidiol and Metabolites in Blood following Vaporization and Oral Ingestion of Cannabidiol Products.
    Bergeria CL; Spindle TR; Cone EJ; Sholler D; Goffi E; Mitchell JM; Winecker RE; Bigelow GE; Flegel R; Vandrey R
    J Anal Toxicol; 2022 Jul; 46(6):583-591. PubMed ID: 35438179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A naturalistic study of orally administered vs. inhaled legal market cannabis: cannabinoids exposure, intoxication, and impairment.
    Bidwell LC; Karoly HC; Torres MO; Master A; Bryan AD; Hutchison KE
    Psychopharmacology (Berl); 2022 Feb; 239(2):385-397. PubMed ID: 34708254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.